Product
BNT162b2 mRNA
1 clinical trial
2 indications
Indication
immune responseIndication
SafetyClinical trial
Immunogenicity and Safety of Concomitant Administration of Omicron-containing Bivalent COVID-19 Vaccines With Seasonal Influenza VaccinesStatus: Completed, Estimated PCD: 2022-12-15